Inhibition of zoledronic acid derivatives with extended methylene linkers on osteoclastogenesis involve downregulation of JNK and Akt pathways-Reference-Cited by-同舟云学术

Inhibition of zoledronic acid derivatives with extended methylene linkers on osteoclastogenesis involve downregulation of JNK and Akt pathways

Published:2021-01-21 Issue:5 Volume:45 Page:1015-1029
ISSN:1065-6995
Container-title:Cell Biology International
language:en
Short-container-title:Cell Biol Int

Author:

Peng Ying¹²^ORCID,Liu Qingzhu¹,Xu Dong¹,Li Ke¹,Li Hang¹³,Qiu Ling¹³,Lin Jianguo¹²

Affiliation:

1. NHC Key Laboratory of Nuclear Medicine, Jiangsu Key Laboratory of Molecular Nuclear Medicine Jiangsu Institute of Nuclear Medicine Wuxi Jiangsu China

2. Department of Radiopharmaceuticals, School of Pharmacy Nanjing Medical University Nanjing Jiangsu China

3. School of Chemical and Material Engineering Jiangnan University Wuxi China

Funder

National Natural Science Foundation of China

Jiangsu Provincial Medical Youth Talent

Publisher

Wiley

Subject

Cell Biology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cbin.11546

Reference51 articles.

1. The molecular understanding of osteoclast differentiation

2. Efficacy of zoledronic acid treatment in Paget disease of bone

3. Farnesyl Pyrophosphate Synthase Is the Molecular Target of Nitrogen-Containing Bisphosphonates

4. Binding and antiresorptive properties of heterocycle-containing bisphosphonate analogs: structure-activity relationships

5. Implication of the calcium sensing receptor and the Phosphoinositide 3-kinase/Akt pathway in the extracellular calcium-mediated migration of RAW 264.7 osteoclast precursor cells

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. M4IDP stimulates ROS elevation through inhibition of mevalonate pathway and pentose phosphate pathway to inhibit colon cancer cells;Biochemical Pharmacology;2023-11

2. M4idp Stimulates ROS Elevation Through Inhibition of Mevalonate Pathway and Pentose Phosphate Pathway to Inhibit Colon Cancer Cells;2023

3. How zoledronic acid improves osteoporosis by acting on osteoclasts;Frontiers in Pharmacology;2022-08-25

4. Tereticornate A suppresses RANKL-induced osteoclastogenesis via the downregulation of c-Src and TRAF6 and the inhibition of RANK signaling pathways;Biomedicine & Pharmacotherapy;2022-07